Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Last data update: Jun 30, 2022. (Total: 47971 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 469 Records)

Next

Query Trace: Prostate cancer[original query]>>Original Studies[Product Type]
Predicting biochemical recurrence of prostate cancer with artificial intelligence.
Pinckaers Hans et al. Communications medicine 2022 264
Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With Prostate Cancer.
Guin Sunny et al. JCO clinical cancer informatics 2022 6e2200010
Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
Giri Veda N et al. JCO precision oncology 2022 6e2200234
Validation of the Decipher Genomic Classifier in Patients receiving Salvage Radiotherapy without Hormone Therapy after Radical Prostatectomy - An Ancillary Study of the SAKK 09/10 Randomized Clinical Trial.
Pra A Dal et al. Annals of oncology : official journal of the European Society for Medical Oncology 2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
Liu Alex J et al. The Prostate 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
A Esteva et al, NPJ Digital Medicine, June 8, 2022
Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men.
Heise Marta et al. Cancer control : journal of the Moffitt Cancer Center 2022 2910732748211062342
The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters.
Rakovic Kai et al. Diagnostics (Basel, Switzerland) 2022 12(5)
Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading.
Wulczyn Ellery et al. Communications medicine 2022 110
Genome-wide risk prediction of common diseases across ancestries in one million people.
Mars Nina et al. Cell genomics 2022 2(4) None
Germline pathogenic variants in unselected Korean men with prostate cancer.
So Min-Kyung et al. Investigative and clinical urology 2022 63(3) 294-300
Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer.
Kazama Hirotaka et al. BMC cancer 2022 22(1) 470
Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool.
Anderson Ashley B et al. BMC cancer 2022 22(1) 476
Development of a clinical polygenic risk score assay and reporting workflow.
Hao Limin et al. Nature medicine 2022
Artificial intelligence supporting cancer patients across Europe-The ASCAPE project.
Tzelves Lazaros et al. PloS one 2022 17(4) e0265127
Association of Family History of Cancer with Clinical and Pathological Outcomes for Prostate Cancer Patients on Active Surveillance.
Jibara Ghalib A et al. The Journal of urology 2022 101097JU0000000000002668
Prostate cancer polygenic risk score and prediction of lethal prostate cancer.
Klein Robert J et al. NPJ precision oncology 2022 6(1) 25
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer.
Graf Ryon P et al. JAMA network open 2022 5(3) e225394
Polygenic risk for prostate cancer: Decreasing relative risk with age but little impact on absolute risk.
Schaid Daniel J et al. American journal of human genetics 2022
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer
RP Graf et al, JAMA Network Open, March 31, 2022
Prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives.
Zheng Guoqiao et al. Cancer medicine 2022
Machine learning-based prediction of upgrading on magnetic resonance imaging targeted biopsy in patients eligible for active surveillance.
ElKarami Bashier et al. Urologic oncology 2022
Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations.
Annoni Anna Maria et al. PloS one 2022 17(3) e0265387
Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate Cancer.
Ramamurthy Chethan et al. Clinical genitourinary cancer 2022
Racial Disparities in Prostate Cancer: Evaluation of Diet, Lifestyle, Family History, and Screening Patterns.
Hansen Megan et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022
Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer.
Press Benjamin H et al. European urology open science 2022 37113-119
Hereditary cancer risk assessment and genetic testing in the community urology practice setting.
Shore Neal D et al. The Prostate 2022
A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies.
Singhal Nitin et al. Scientific reports 2022 12(1) 3383
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.
Cyrta Joanna et al. The Journal of pathology 2022
A Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers.
Huang Wei et al. JCO clinical cancer informatics 2022 6e2100131
TOP